Publication | Closed Access

A phase I trial in HIV negative healthy volunteers evaluating the effect of potent adjuvants on immunogenicity of a recombinant gp120W61D derived from dual tropic R5X4 HIV-1ACH320

Primary ImmunodeficiencyHuman RetrovirusImmunologyAntiviral TherapyAntiviral ResponseRecombinant Gp120w61dPotent AdjuvantsHivImmunotherapyMedicine